Literature DB >> 15194116

NMDA receptors are movin' in.

Yi Nong1, Yue-Qiao Huang, Michael W Salter.   

Abstract

Dynamic modulation of the number of postsynaptic glutamate receptors is considered one of the main mechanisms for altering the strength of excitatory synapses in the central nervous system (CNS). However, until recently N-methyl-d-aspartate (NMDA) receptors were considered relatively stable once in the plasma membrane, especially in comparison with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors that are internalized at a high rate. A series of recent studies has changed this viewpoint by revealing that NMDA receptors are subject to constitutive as well as agonist-induced internalization through clathrin-mediated endocytosis. Surprisingly, agonist-induced internalization is not dependent on current flow through the NMDA channel, and the receptors are primed for this type of internalization by selective stimulation of the glycine site but not of the glutamate site. Endocytosis of NMDA receptors provides a fundamental mechanism for dynamic regulation of the number of NMDA receptors at synapses, which might be important for physiological and pathological functioning of the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194116     DOI: 10.1016/j.conb.2004.05.001

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  32 in total

1.  The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2.

Authors:  Kate Prybylowski; Kai Chang; Nathalie Sans; Lilly Kan; Stefano Vicini; Robert J Wenthold
Journal:  Neuron       Date:  2005-09-15       Impact factor: 17.173

2.  Dual role of the exocyst in AMPA receptor targeting and insertion into the postsynaptic membrane.

Authors:  Nashaat Z Gerges; Donald S Backos; Chamila N Rupasinghe; Mark R Spaller; José A Esteban
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

Review 3.  Running to stand still: ionotropic receptor dynamics at central and peripheral synapses.

Authors:  Emile G Bruneau; Mohammed Akaaboune
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

4.  Long-term potentiation selectively expressed by NMDA receptors at hippocampal mossy fiber synapses.

Authors:  Hyung-Bae Kwon; Pablo E Castillo
Journal:  Neuron       Date:  2008-01-10       Impact factor: 17.173

5.  Mobility of NMDA autoreceptors but not postsynaptic receptors at glutamate synapses in the rat entorhinal cortex.

Authors:  Jian Yang; Sophie E L Chamberlain; Gavin L Woodhall; Roland S G Jones
Journal:  J Physiol       Date:  2008-08-21       Impact factor: 5.182

Review 6.  Anti-NMDA receptor encephalitis: a review of mechanistic studies.

Authors:  Yue-Qiao Huang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-02-15

7.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

8.  Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.

Authors:  Sumie Leung; Rodney J Croft; Barry V O'Neill; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

9.  Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.

Authors:  Jian-Li Hu; Gang Liu; Yan-Chun Li; Wen-Jun Gao; Yue-Qiao Huang
Journal:  Mol Brain       Date:  2010-06-22       Impact factor: 4.041

10.  The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.

Authors:  Emmanuel Kostakis; Conor Smith; Ming-Kuei Jang; Stella C Martin; Kyle G Richards; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  Mol Pharmacol       Date:  2013-05-28       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.